Genomics plc Publishes Clinical Trial Results Demonstrating Successful Integration and Clinical Utility of Integrated Risk Scores Combining Polygenic and Clinical Risk of Cardiovascular Disease in NHS Primary Care
DAIC
FEBRUARY 1, 2024
The HEART Study is the world's first clinical trial investigating the use of genomic 'polygenic risk score (PRS) testing' to support the prevention of cardiovascular disease ( CVD ) in National Health Service (NHS) clinical practice. Prevention is at the heart of what we do as GPs and risk assessment underpins that.
110 
Let's personalize your content